In Most Consumers' OTC Pain Relief Decisions, Safety Missing As A Factor
This article was originally published in The Pink Sheet
Most US consumers choose pain relievers based on speed and efficacy instead of factors critical to safe use – age, health conditions and use of other OTCs and drugs – according to a survey supported by J&J/McNeil.
You may also be interested in...
While self-reported pain is up more than 10%, consumers are more educated on safe pain management using acetaminophen since CHPA's previous survey in 2019.
J&J/McNeil may continue to advertise the Tylenol line ahead of the first case in multi-district litigation claiming use of the products as labeled is linked to liver damage, says a federal judge. The plaintiff asked the court to prohibit the firm from advertising that could taint the juror pool ahead of the fall trial.
CDER publishes a Drug Safety Communication, a consumer announcement and a MedWatch notice warning about the risk of serious bleeding when using OTC aspirin-containing antacid products.